Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v39-EN Version v32-EN
Language English English
Date Updated 2019-03-15 2019-01-17
Drug Identification Number 00363812 00363812
Brand name BUSCOPAN BUSCOPAN
Common or Proper name Buscopan 10mg Buscopan 10mg
Company Name SANOFI CONSUMER HEALTH INC SANOFI CONSUMER HEALTH INC
Ingredients HYOSCINE BUTYLBROMIDE HYOSCINE BUTYLBROMIDE
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code A03BB A03BB
ATC description BELLADONNAAND DERIVATIVES, PLAIN BELLADONNAAND DERIVATIVES, PLAIN
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2018-01-15 2018-01-15
Actual start date 2018-01-15 2018-01-15
Estimated end date 2019-06-01 2019-06-01
Actual end date 2019-03-14
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. Supply delay
Health Canada comments